DSIJ Mindshare

Lupin receives USFDA approval for Mycophenolate Mofetil tablets

Rishikesh Gaikwad 0 1448 Article rating: 2.4

Lupin Limited announced on Thursday that it has received approval from United States Food and Drug Administration (USFDA) for Mycophenolate Mofetil tablets USP, 500 mg, to market a generic version of CellCept® tablets of Roche Palo Alto LLC (Roche) in alliance with Concord Biotech Limited.

Vaillant Group partners with TCS

Rishikesh Gaikwad 0 2008 Article rating: 3.4

Tata Consultancy Services (TCS) has expanded partnership with Vaillant Group, a global leader in heating, ventilation and air-conditioning technology, to streamline the latter’s business processes and implement those on a single, digital enterprise process platform to support its business model transformation and future growth.

RSS
First7891012141516Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR